ESTRO 2025 - Abstract Book

S1608

Clinical – Mixed sites & palliation

ESTRO 2025

Conclusion: Low-dose radiotherapy has demonstrated significant reductions in pain (Figura 1), and it can also prevent or delay the need for surgery, offering an alternative for patients who are refractory to conventional treatments. The next step will be to evaluate functional outcomes and quality of life using a longer follow-up period.

Keywords: RADIOTHERAPY, LEDDERHOSE, DISEASE

4479

Digital Poster First patients treated with discrete Proton Arc Therapy at the Proton Therapy Centre in Trento Marco Cianchetti 1 , Francesco Fracchiolla 1 , Irene Giacomelli 1 , Benedetta Siniscalchi 1 , Barbara Rombi 1 , Roberto Righetto 2 , Annalisa Trianni 2 , Stefano Lorentini 2 , Frank Reinhard Lohr 1,3 1 Proton Therapy, Trento Hospital, APSS, Trento, Italy. 2 Fisica Sanitaria, Trento Hospital, APSS, Trento, Italy. 3 CISMed, Università di Trento, Trento, Italy Purpose/Objective: Treating Head and Neck and skull base cancer patients is a challenge because of the anatomical complexity of the region that makes radiotherapy planning difficult as a delicate balance between target coverage and organ at risk (OAR) sparing has to be found.